# Tb-PSMA-I&T Radionuclide Before Radical Prostatectomy in Patients With Locally Advanced Prostate Cancer - TbeforePROST Trial.

> **NCT07208240** · PHASE1,PHASE2 · RECRUITING · sponsor: **Rabin Medical Center** · enrollment: 20 (estimated)

## Conditions studied

- High Risk Prostate Cancer

## Interventions

- **DRUG:** Tb-PSMA-I&T (Tb-PSMA)

## Key facts

- **NCT ID:** NCT07208240
- **Lead sponsor:** Rabin Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-12
- **Primary completion:** 2028-08-12
- **Final completion:** 2028-08-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07208240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07208240, "Tb-PSMA-I&T Radionuclide Before Radical Prostatectomy in Patients With Locally Advanced Prostate Cancer - TbeforePROST Trial.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07208240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*